Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

The androgen receptor represses transforming growth factor-beta signaling through interaction with Smad3.

In the prostate, androgens negatively regulate the expression of transforming growth factor-beta (TGF-beta) ligands and receptors and Smad activation through unknown mechanisms. We show that androgens (dihydrotestosterone and R1881) down-regulate TGF-beta1-induced expression of TGF-beta1, c-Fos, and Egr-1 in the human prostate adenocarcinoma cell line, LNCaP. Moreover, 5alpha-dihydrotestosterone (DHT) inhibits TGF-beta1 activation of three TGF-beta1-responsive promoter constructs, 3TP-luciferase, AP-1-luciferase, and SBE4(BV)-luciferase, in LNCaP cells either with or without enforced expression of TGF-beta receptors (TbetaRI and TbetaRII). Similarly, DHT inhibits the activation of Smad-binding element (SBE)4(BV)-luciferase by either constitutively activated TbetaRI (T204D) or constitutively activated Smad3 (S3*). Activation of SBE4(BV)-luciferase by S3* in the NRP-154 prostatic cell line, which is androgen receptor (AR)-negative but highly responsive to TGF-beta1, is blocked by co-transfection with either full-length AR or AR missing the DNA binding domain. Immunoprecipitation and GST pull-down assays show that AR directly associates with Smad3 but not Smad2 or Smad4. Electrophoretic mobility shift assays indicate that the AR ligand binding domain directly inhibits the association of Smad3 to the Smad-binding element. In conclusion, our data demonstrate for the first time that ligand-bound AR inhibits TGF-beta transcriptional responses through selectively repressing the binding of Smad3 to SBE.

Pubmed ID: 11707452


  • Chipuk JE
  • Cornelius SC
  • Pultz NJ
  • Jorgensen JS
  • Bonham MJ
  • Kim SJ
  • Danielpour D


The Journal of biological chemistry

Publication Data

January 11, 2002

Associated Grants

  • Agency: NCI NIH HHS, Id: 1R01-CA3069-01
  • Agency: NCI NIH HHS, Id: P30CA43703

Mesh Terms

  • Adenocarcinoma
  • Cycloheximide
  • DNA-Binding Proteins
  • Dactinomycin
  • Dihydrotestosterone
  • Early Growth Response Protein 1
  • Gene Expression Regulation
  • Genes, Reporter
  • Humans
  • Immediate-Early Proteins
  • Ligands
  • Male
  • Metribolone
  • Prostatic Neoplasms
  • Protein Synthesis Inhibitors
  • Proto-Oncogene Proteins c-fos
  • Receptors, Androgen
  • Signal Transduction
  • Smad3 Protein
  • Testosterone Congeners
  • Trans-Activators
  • Transcription Factors
  • Transfection
  • Transforming Growth Factor beta
  • Tumor Cells, Cultured